Victory Capital Management Inc Autolus Therapeutics PLC Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$3.33 - $5.68 $8,591 - $14,654	-2,580 Reduced 1.91%	132,580 $461,000
Q1 2024 May 03, 2024	BUY	$5.39 - $7.29 $85,862 - $116,129	15,930 Added 13.36%	135,160 $862,000
Q4 2023 Feb 05, 2024	BUY	$2.13 - $6.63 $253,959 - $790,494	119,230 New	119,230 $767,000
Q2 2021 Aug 03, 2021	SELL	$4.78 - $7.96 $28,746 - $47,871	-6,014 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$5.49 - $9.36 $401,351 - $684,272	-73,106 Reduced 92.4%	6,014 $34,000
Q4 2020 Feb 01, 2021	SELL	$8.13 - $12.79 $105,852 - $166,525	-13,020 Reduced 14.13%	79,120 $707,000
Q3 2020 Nov 09, 2020	SELL	$11.64 - $16.3 $32,708 - $45,803	-2,810 Reduced 2.96%	92,140 $1.07 Million
Q2 2020 Aug 07, 2020	SELL	$5.38 - $16.14 $1.29 Million - $3.88 Million	-240,472 Reduced 71.69%	94,950 $1.52 Million
Q1 2020 May 04, 2020	BUY	$4.2 - $13.0 $370,587 - $1.15 Million	88,235 Added 35.7%	335,422 $2.01 Million
Q4 2019 Feb 06, 2020	SELL	$11.13 - $16.28 $1.09 Million - $1.6 Million	-98,300 Reduced 28.45%	247,187 $3.26 Million
Q4 2019 Feb 04, 2020	BUY	$11.13 - $16.28 $571,269 - $835,603	51,327 Added 17.45%	345,487 $3.39 Million
Q3 2019 Nov 12, 2019	BUY	$9.79 - $16.72 $1.94 Million - $3.32 Million	198,600 Added 207.83%	294,160 $3.65 Million
Q2 2019 Aug 15, 2019	BUY	$15.1 - $31.25 $805,283 - $1.67 Million	53,330 Added 126.28%	95,560 $1.54 Million
Q1 2019 May 03, 2019	SELL	$24.38 - $34.71 $11,458 - $16,313	-470 Reduced 1.1%	42,230 $1.33 Million
Q4 2018 Feb 05, 2019	SELL	$24.21 - $48.01 $871,075 - $1.73 Million	-35,980 Reduced 45.73%	42,700 $1.4 Million
Q3 2018 Nov 01, 2018	SELL	$20.86 - $33.33 $841,492 - $1.34 Million	-40,340 Reduced 33.89%	78,680 $2.37 Million
Q2 2018 Aug 02, 2018	BUY	$25.0 - $27.75 $2.98 Million - $3.3 Million	119,020 New	119,020 $3.19 Million

Others Institutions Holding AUTL

# of Institutions

104

Shares Held

163M

Call Options Held

2.8K

Put Options Held

13.4K

Wellington Management Group LLP Boston, MA

24.2M
Shares

$72.4 Million
0.02% of portfolio
Blackstone Inc New York, NY

20.5M
Shares

$61.3 Million
0.35% of portfolio
Syncona Portfolio LTD Guernsey, Channel Islands, X0

18.6M
Shares

$55.5 Million
83.42% of portfolio
Deep Track Capital, LP Greenwich, CT

15.3M
Shares

$45.7 Million
2.04% of portfolio
Avoro Capital Advisors LLC New York, NY

12.3M
Shares

$36.9 Million
0.67% of portfolio

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $272M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account